Mr. Wei Zhao

Medical Professional
Shanghai Shuguang Hospital, China


Highest Degree
Ph.D. Student in Biomolecular Science from Saga University, Saga, Japan

Share this Profile

Area of Interest:

Biomedical Sciences
Cardiovascular Medicine
Heart Failure
Hypertension
Coronary Heart Disease

Selected Publications

  1. Zhao, W., W. Hu, X. Wang, N. Xia, Q. Hu and H. Zhou, 2015. A traditional Chinese medicine, Lujiao prescription, as a potential therapy for hypertrophic cardiomyocytes by acting on histone acetylation. J. Chin. Med. Assoc., 78: 486-493.
    CrossRef  |  PubMed  |  Direct Link  |  

  2. Zhao, W., H. Soejima, T. Nakagawachi, T. Urano and S. Kudo et al., 2005. The essential role of histone H3 Lys9 Di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island. J. Biochem., 137: 431-440.
    CrossRef  |  PubMed  |  Direct Link  |  

  3. Soejima, H., W. Zhao and T. Mukai, 2005. Epigenetic silencing of the MGMT gene in cancer. Biochem. Cell. Biol., 83: 429-437.
    CrossRef  |  PubMed  |  Direct Link  |  

  4. Soejima, H., T. Nakagawachi, W. Zhao, K. Higashimoto and T. Urano et al., 2004. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer. Oncogene, 23: 4380-4388.
    CrossRef  |  PubMed  |  Direct Link  |  

  5. Nakagawachi, T., H. Soejima, T. Urano, W. Zhao and K. Higashimoto et al., 2003. Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer. Oncogene, 22: 8835-8844.
    CrossRef  |  PubMed  |  Direct Link  |